Cargando…
Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing
Introduction: Hemophilia A (HA) is the most common genetic bleeding disorder caused by mutations in the F8 gene encoding coagulation factor VIII (FVIII). As the second predominant pathogenic mutation in hemophilia A severe patients, F8 Intron one inversion (Inv1) completely splits the F8 gene into t...
Autores principales: | Hu, Zhiqing, Wu, Yong, Xiao, Rou, Zhao, Junya, Chen, Yan, Wu, Lingqian, Zhou, Miaojin, Liang, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033665/ https://www.ncbi.nlm.nih.gov/pubmed/36968612 http://dx.doi.org/10.3389/fgene.2023.1115831 |
Ejemplares similares
-
CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B
por: Tang, Qiyu, et al.
Publicado: (2023) -
ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
por: Hu, Zhiqing, et al.
Publicado: (2019) -
In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs
por: Wu, Yong, et al.
Publicado: (2016) -
Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes
por: Xiao, Rou, et al.
Publicado: (2022) -
Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From F8-Modified iPSCs
por: Qiu, Liyan, et al.
Publicado: (2021)